Case Study of Custom Buffer Implementation for Regenerative Medicine
Custom buffer supporting scaffold fabrication in regenerative medicine.
In the regenerative medicine industry, particularly in scaffold fabrication, the survival and functional maintenance of cells are crucial. The appropriate selection of buffers is essential for optimizing the cellular environment and enhancing compatibility with scaffold materials. If the composition of the buffer is unstable or if manufacturing takes too long, it can lead to decreased efficiency in scaffold fabrication and potential delays in research and development or treatment. In our custom buffer implementation case, we provide buffers tailored to customer needs, supporting solutions to challenges in scaffold fabrication. 【Application Scenarios】 - Scaffold fabrication in regenerative medicine - Cell culture - Cell preservation 【Benefits of Implementation】 - Improved cell survival rates - Enhanced compatibility with scaffold materials - Increased efficiency in research and development
basic information
**Features** - Contract manufacturing of customer-specific buffer compositions - Stable supply system through collaboration with single-use bag manufacturers - Delivery aligned with the timing of product use - Support for long-term stability testing **Our Strengths** - Contract manufacturing compliant with GMP - Development technology for medium raw materials and compositions based on high-quality amino acids - Advanced production technology for liquid media - Extensive track record in the field of regenerative medicine
Price range
Delivery Time
Applications/Examples of results
【Usage】 ■ Buffer for Cultivation and Purification *For more details, please refer to the related links or feel free to contact us.
catalog（2）
Download All Catalogs
Recommended products
Distributors
In June 2018, we established Ajinomoto Koji Bio Co., Inc. as a joint venture between Ajinomoto Co., Inc. and Koji Bio Co., Inc. We combined Ajinomoto Co., Inc.'s high-quality amino acids as the foundation for culture media raw materials and their formulation development technology with Koji Bio Co., Inc.'s advanced liquid culture media production technology to launch a contract manufacturing company for clinical culture media necessary for regenerative medicine. Currently, we are engaged in contract manufacturing of liquid media and buffers for customers in cell therapy and biopharmaceuticals, enhancing our significance in the industry.